Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alimera Sciences Inc (NQ: ALIM )

4.200 -0.070 (-1.64%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,591
Open 4.274
Bid (Size) 3.980 (1)
Ask (Size) 5.950 (1)
Prev. Close 4.270
Today's Range 4.150 - 4.323
52wk Range 3.940 - 10.50
Shares Outstanding 7,002,961
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Alimera Sciences Q1 Earnings
Alimera Sciences (NASDAQ:ALIM) reported its Q1 earnings results on Monday, May 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public... 
From MicroCap Rodeo
Via AccessWire

Performance

YTD
-15.49%
-15.49%
1 Month
-31.03%
-31.03%
3 Month
-12.32%
-12.32%
6 Month
-26.70%
-26.70%
1 Year
-53.69%
-53.69%

More News

Read More
2 Moonshots That Insiders Are Buying… and 3 They’re Not
Via InvestorPlace
64 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
92 Biggest Movers From Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
64 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
3 Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Alimera Sciences, inc (ALIM) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Via Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
Alimera Sciences, inc (ALIM) Q2 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Alimera Sciences Q2 Earnings
Via Benzinga
Earnings Scheduled For August 13, 2021
Via Benzinga
How Does Alimera Sciences's Debt Look?
Via Benzinga
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
From MicroCap Rodeo
Via AccessWire
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Via Benzinga
Exposures Product Safety
Alimera Sciences Inc (ALIM) Q1 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Via Benzinga
Recap: Alimera Sciences Q1 Earnings
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.